Company Filing History:
1 out of 46 
1 out of 2 Years Active: 2021-2025
Title: The Innovations of Inventor Li Li
Introduction
Li Li is an accomplished inventor based in Downington, PA (US). He has made significant contributions to the field of immunology, particularly in the area of regulatory T cells. With a total of 2 patents, his work focuses on enhancing the suppressive function of these cells for clinical applications in immune-mediated diseases.
Latest Patents
Li Li's latest patents include a groundbreaking method for the ex-vivo expansion of regulatory T cells with enhanced suppressive function. This invention provides methods for the ex-vivo expansion of CD4+CD25+ Tregs. The method aims to produce ex vivo expanded Tregs that can inhibit unwanted human immune responses against self-antigens or allergens. Additionally, these ex vivo expanded Tregs may offer treatment options for inflammatory and autoimmune diseases.
Career Highlights
Throughout his career, Li Li has worked with notable companies such as Mallinckrodt Pharmaceuticals Ireland Limited and Therakos Development Limited. His experience in these organizations has contributed to his expertise in the field of immunology and patent development.
Collaborations
Li Li has collaborated with various professionals in his field, including his coworker Tinghua Cao, who has also made significant contributions to their shared projects.
Conclusion
Li Li's innovative work in the expansion of regulatory T cells showcases his dedication to advancing medical science. His patents reflect a commitment to finding solutions for immune-mediated diseases, making him a notable figure in the field of immunology.